Centiva Capital, LP Nuvasive Inc Transaction History

Centiva Capital, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$36.71 - $44.15 $109,359 - $131,522	2,979 Added 29.22%	13,175 $547,000
Q1 2023 May 15, 2023	BUY	$36.81 - $48.12 $375,314 - $490,631	10,196 New	10,196 $421,000
Q3 2022 Nov 14, 2022	BUY	$42.51 - $54.02 $47,781 - $60,718	1,124 New	1,124 $49,000
Q1 2022 May 16, 2022	SELL	$48.09 - $57.79 $671,865 - $807,384	-13,971 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$47.19 - $62.68 $659,291 - $875,702	13,971 New	13,971 $733,000
Q3 2021 Nov 15, 2021	SELL	$56.91 - $67.81 $530,173 - $631,717	-9,316 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$64.02 - $71.72 $23,303 - $26,106	364 Added 4.07%	9,316 $631,000
Q1 2021 May 17, 2021	BUY	$53.26 - $68.08 $476,783 - $609,452	8,952 New	8,952 $587,000
Q4 2019 Feb 14, 2020	SELL	$60.96 - $77.7 $401,970 - $512,353	-6,594 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$55.78 - $68.08 $367,813 - $448,919	6,594 New	6,594 $418,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.